These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 9341755

  • 1. Biologically active, alternatively processed interleukin-1 beta in psoriatic scales.
    Lundqvist EN, Egelrud T.
    Eur J Immunol; 1997 Sep; 27(9):2165-71. PubMed ID: 9341755
    [Abstract] [Full Text] [Related]

  • 2. Biological activity of human epidermal interleukin-1beta: comparison with recombinant human interleukin-1beta.
    Lundqvist EN, Companjen AR, Prens EP, Egelrud T.
    Eur Cytokine Netw; 1998 Mar; 9(1):41-6. PubMed ID: 9613676
    [Abstract] [Full Text] [Related]

  • 3. IL-1 beta activation in human epidermis.
    Nylander-Lundqvist E, Bäck O, Egelrud T.
    J Immunol; 1996 Aug 15; 157(4):1699-704. PubMed ID: 8759758
    [Abstract] [Full Text] [Related]

  • 4. Purification and characterization of interleukin 1 beta from human plantar stratum corneum. Evidence of interleukin 1 beta processing in vivo not involving interleukin 1 beta convertase.
    Brattsand M, Egelrud T.
    Cytokine; 1998 Jul 15; 10(7):506-13. PubMed ID: 9702414
    [Abstract] [Full Text] [Related]

  • 5. Neutrophil chemoattractant and IL-1-like activity in samples from psoriatic skin lesions. Further characterization.
    Fincham NJ, Camp RD, Gearing AJ, Bird CR, Cunningham FM.
    J Immunol; 1988 Jun 15; 140(12):4294-9. PubMed ID: 3286771
    [Abstract] [Full Text] [Related]

  • 6. IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta.
    Cooper KD, Hammerberg C, Baadsgaard O, Elder JT, Chan LS, Sauder DN, Voorhees JJ, Fisher G.
    J Immunol; 1990 Jun 15; 144(12):4593-603. PubMed ID: 2191038
    [Abstract] [Full Text] [Related]

  • 7. Enhanced production of biologically active interleukin-1 alpha and interleukin-1 beta by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1 beta levels and facilitated interleukin-1 release.
    Debets R, Hegmans JP, Troost RJ, Benner R, Prens EP.
    Eur J Immunol; 1995 Jun 15; 25(6):1624-30. PubMed ID: 7614991
    [Abstract] [Full Text] [Related]

  • 8. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
    Debets R, Hegmans JP, Croughs P, Troost RJ, Prins JB, Benner R, Prens EP.
    J Immunol; 1997 Mar 15; 158(6):2955-63. PubMed ID: 9058835
    [Abstract] [Full Text] [Related]

  • 9. Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes.
    Mizutani H, Black R, Kupper TS.
    J Clin Invest; 1991 Mar 15; 87(3):1066-71. PubMed ID: 1999487
    [Abstract] [Full Text] [Related]

  • 10. Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions.
    Companjen A, van der Wel L, van der Fits L, Laman J, Prens E.
    Eur Cytokine Netw; 2004 Mar 15; 15(3):210-6. PubMed ID: 15542445
    [Abstract] [Full Text] [Related]

  • 11. IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.
    Bonifati C, Carducci M, Mussi A, D'auria L, Ameglio F.
    J Biol Regul Homeost Agents; 1997 Mar 15; 11(4):133-6. PubMed ID: 9582612
    [Abstract] [Full Text] [Related]

  • 12. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC.
    Invest Ophthalmol Vis Sci; 2001 Sep 15; 42(10):2283-92. PubMed ID: 11527941
    [Abstract] [Full Text] [Related]

  • 13. Ubiquitous interleukin-1 alpha in fetal bovine serum may mislead the experimental results in vitro.
    Hida S, Takeuchi A, Hayashi H, Yano T, Hopkins SJ, Onozaki K.
    Eur Cytokine Netw; 1995 Sep 15; 6(2):121-6. PubMed ID: 7578990
    [Abstract] [Full Text] [Related]

  • 14. Psoriatic skin lesions contain biologically active amounts of an interleukin 1-like compound.
    Camp RD, Fincham NJ, Cunningham FM, Greaves MW, Morris J, Chu A.
    J Immunol; 1986 Dec 01; 137(11):3469-74. PubMed ID: 3491138
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment.
    Oxholm A, Oxholm P, Staberg B, Bendtzen K.
    Acta Derm Venereol; 1989 Dec 01; 69(3):195-9. PubMed ID: 2566221
    [Abstract] [Full Text] [Related]

  • 16. Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity.
    Horrocks C, Holder JE, Berth-Jones J, Camp RD.
    Br J Dermatol; 1997 Sep 01; 137(3):331-8. PubMed ID: 9349325
    [Abstract] [Full Text] [Related]

  • 17. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.
    Schönbeck U, Mach F, Libby P.
    J Immunol; 1998 Oct 01; 161(7):3340-6. PubMed ID: 9759850
    [Abstract] [Full Text] [Related]

  • 18. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
    Oxholm A.
    APMIS Suppl; 1992 Oct 01; 24():1-32. PubMed ID: 1567657
    [Abstract] [Full Text] [Related]

  • 19. Doxycycline inhibition of interleukin-1 in the corneal epithelium.
    Solomon A, Rosenblatt M, Li DQ, Liu Z, Monroy D, Ji Z, Lokeshwar BL, Pflugfelder SC.
    Invest Ophthalmol Vis Sci; 2000 Aug 01; 41(9):2544-57. PubMed ID: 10937565
    [Abstract] [Full Text] [Related]

  • 20. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha.
    Howard AD, Kostura MJ, Thornberry N, Ding GJ, Limjuco G, Weidner J, Salley JP, Hogquist KA, Chaplin DD, Mumford RA.
    J Immunol; 1991 Nov 01; 147(9):2964-9. PubMed ID: 1919001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.